Arkana Therapeutics

Arkana Therapeutics is a Boulder, Colorado-based biotech spun out of the lab of Leslie Leinwand at the University of Colorado Boulder, developing oral small-molecule therapies for obesity and metabolic disease. Its approach is inspired by python biology: after a large meal, Burmese pythons flood their blood with a metabolite that rises roughly 1,000-fold and acts as a natural appetite suppressant, and Arkana turns that biology into medicines that reduce calorie intake and raise energy expenditure through mechanisms beyond GLP-1. Co-founded in 2025 by CEO Jack Gugel with Leinwand, Thomas Martin and Jonathan Long of Stanford, the company is advancing two oral pipeline programs, ARK-100 (appetite suppression) and ARK-200 (energy expenditure).

  • Pre-Seed
  • Biotechnology
  • Healthtech
  • Healthcare & Life Sciences

1

Round

1

Industry

3

Tags

Nov 19, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 19, 2026

    $3M

    Pre-Seed

    • Boulder Angels

    Arkana Therapeutics Raises $3M Pre-Seed for Oral Obesity and Metabolic Therapies

    Arkana Therapeutics, a Boulder, Colorado based biotech, has raised a $3 million pre seed round. The round was funded by Boulder Angels, with no lead investor d…

    Read article

Pricing

Research Arkana Therapeutics — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Arkana Therapeutics is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational